Filtered By:
Procedure: Hemodialysis
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 24907 results found since Jan 2013.
Assessment of a hemodialysis E-curriculum in postgraduate nephrology education: A pilot mixed methods study
CONCLUSION: Our study highlights the effectiveness of an asynchronous E-curriculum in promoting active learning in nephrology and provides a framework for E-curricula development. Further study is needed to assess its impact on changes in learner attitude and patient outcomes.PMID:36149024 | DOI:10.5414/CN110778
Source: Clinical Nephrology - September 23, 2022 Category: Urology & Nephrology Authors: Namrata Krishnan Erin Brannan Janet Hafler Emma Brennan-Wydra John Encandela Source Type: research
Accuracy of dialysis medical records in determining patients' interest in and suitability for transplantation
ConclusionDialysis medical records are frequently inaccurate in determining patient's interest in and suitability for transplantation.
Source: Clinical Transplantation - June 27, 2013 Category: Transplant Surgery Authors: Anne M. Huml, Catherine M. Sullivan, Julie A. Pencak, Ashwini R. Sehgal Tags: Original Article Source Type: research
The economic burden of hemodialysis in Jordan
Conclusions: Costs of treating and managing patients on hemodialysis at MOH hospitals in Jordan are substantial. Therefore, efforts should be taken to slow down the progress of renal failure to save resources and a comparative study with other modalities, such as continuous ambulatory peritoneal dialysis and kidney transplantation, should be considered.
Source: Indian Journal of Medical Sciences - December 5, 2013 Category: Journals (General) Authors: Emad Adel Al-ShdaifatMohd Rizal Abdul Manaf Source Type: research
Boston Scientific, Baxter join TVA Medical’s $15m Series C round
TVA Medical said today it raised $15 million in a Series C financing round to support its everlinQ endoAVF system for creating minimally invasive hemodialysis access, with strategic investments coming from major players Baxter (NYSE:BAX) and Boston Scientific (NYSE:BSX).
The catheter-based system is designed to create an AV fistula used for hemodialysis access. The system uses 2 magnetic catheters which are inserted into an artery and vein in the arm and used to connect the artery and vein to create a fistula, TVA Medical said.
The Series C round was led by newly vested Baxter Ventures and joined by new investor ...
Source: Mass Device - October 6, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters Dialysis Vascular TVA Medical Source Type: news
7 medtech stories we missed this week: Sept. 15, 2017
[Image from unsplash.com]From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention.
1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial
Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to lead its Restrata wound matrix study. The study will surgery the clinical outcomes of Restrata treatments for diabetic foot ulcers and test for effectiveness and safety. Restrata is a fully synthetic wound matrix that is FDA-cleared for woun...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Dental Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Surgical Acera Surgical Contego Medical Fresenius MedTech OBP Medical Pinnacle Sciences Plusoptix Telos Source Type: news
Fresenius Medical Care, Humacyte ink $150m strategic partnership deal
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said today it inked a $150 million strategic partnership deal with Humacyte through which Fresenius will gain exclusive rights to commercialize Humacyte’s Humacyl bioengineered blood vessel technology.
Research Triangle Park, N.C.-based Humacyte is exploring the use of its Humacyl human acellular vessel as a conduit for hemodialysis in patients with end-stage renal disease who cannot have fistula placement.
Fresenius Medical will now be responsible for the marketing, sales and distribution of Humacyl following appropriate regulatory approval, the companies said. Fresenius ...
Source: Mass Device - June 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Vascular Fresenius Humacyte Source Type: news
How sensors are helping hemodialysis move into the home
Providing advanced medical care in a patient’s home once required the help of trained professionals. No longer – new sensor technology is enabling a massive migration from hospitals to home care environments.
Outset Medical’s Tablo home hemodialysis platform features a streamlined touchscreen interface and a small size. But the real core of its effectiveness lies in its sensors. [Image courtesy of Outset Medical]
Medtech is on the move again. New technological advances are enabling systems that have, for years, been shackled to hospitals and clinics, to travel home with their users.
For decades, hemodialysis sys...
Source: Mass Device - September 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Dialysis mHealth (Mobile Health) Outset Medical teconnectivity Source Type: news
Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database.
CONCLUSION: The increasing proportion of medical costs for percutaneous angioplasty represents a challenge in the management of end-stage renal disease in Korea. It is essential to identify the clinical and physiological aspects as well as anatomical abnormalities before planning angioplasty. A timely surgical correction could be a viable option to control the rapid growth of access-related medical expenses.
PMID: 30396254 [PubMed - in process]
Source: The Korean Journal of Internal Medicine - November 1, 2018 Category: Internal Medicine Authors: Lee HS, Ju YS, Song YR, Kim JK, Choi SR, Joo N, Kim HJ, Park P, Kim SG Tags: Korean J Intern Med Source Type: research
The relationship between hemodialysis mortality and the Chinese medical insurance type.
Conclusions: The medical insurance model was independently associated with HD patient survival, NCMS was associated with increased mortality among patients undergoing maintenance hemodialysis in China.
PMID: 31478795 [PubMed - in process]
Source: Renal Failure - September 5, 2019 Category: Urology & Nephrology Tags: Ren Fail Source Type: research
Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial
CONCLUSION: Spironolactone treatment increases PVCs in HD, indicating a possible proarrhythmic effect. However, improved cardiac autonomic function, as indicated by an increased HRV, may contribute to the survival benefit from spironolactone treatment in HD patients.PMID:33613861 | PMC:PMC7886278 | DOI:10.48101/ujms.v126.5660
Source: Upsala Journal of Medical Sciences - February 22, 2021 Category: General Medicine Authors: Michael Eklund Olof Hellberg Hans Furuland Yang Cao Erik Nilsson Source Type: research
